0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intravenous Therapy (IV) Bottles Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-38D14062
Home | Market Reports | Health| Pharmacy
Global Intravenous Therapy IV Bottles Market Research Report 2023
BUY CHAPTERS

Global Intravenous Therapy (IV) Bottles Market Research Report 2025

Code: QYRE-Auto-38D14062
Report
March 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Intravenous Therapy (IV) Bottles Market Size

The global market for Intravenous Therapy (IV) Bottles was valued at US$ 186 million in the year 2024 and is projected to reach a revised size of US$ 245 million by 2031, growing at a CAGR of 4.1% during the forecast period.

Intravenous Therapy (IV) Bottles Market

Intravenous Therapy (IV) Bottles Market

The Intravenous Therapy (IV) Bottles market refers to the segment of the healthcare industry that focuses on the production and distribution of bottles specifically designed for intravenous therapy. These bottles are used to store and administer fluids, medications, and nutrients directly into a patient"s bloodstream through an intravenous line. IV bottles are typically made of plastic or glass and come in various sizes and configurations to accommodate different treatment needs. The market for IV bottles is driven by the growing demand for intravenous therapy in hospitals, clinics, and home healthcare settings. It is also influenced by factors such as advancements in medical technology, increasing prevalence of chronic diseases, and the need for safe and efficient drug delivery systems.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intravenous Therapy (IV) Bottles, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Therapy (IV) Bottles.
The Intravenous Therapy (IV) Bottles market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intravenous Therapy (IV) Bottles market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous Therapy (IV) Bottles manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Intravenous Therapy (IV) Bottles Market Report

Report Metric Details
Report Name Intravenous Therapy (IV) Bottles Market
Accounted market size in year US$ 186 million
Forecasted market size in 2031 US$ 245 million
CAGR 4.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Baxter Healthcare Limited, Vioser SA, B. Braun, Fresenius AG, JW Life Science, Polycine GmbH, Kraton Corporation, Metrix Company, Medicopack A/S, Sippex, ICU Medical, Technoflex S.A, Bausch Group, Euro Healthcare Pvt. Ltd., JOTOP Glass
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Intravenous Therapy (IV) Bottles manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Intravenous Therapy (IV) Bottles in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Intravenous Therapy (IV) Bottles Market growing?

Ans: The Intravenous Therapy (IV) Bottles Market witnessing a CAGR of 4.1% during the forecast period 2025-2031.

What is the Intravenous Therapy (IV) Bottles Market size in 2031?

Ans: The Intravenous Therapy (IV) Bottles Market size in 2031 will be US$ 245 million.

Who are the main players in the Intravenous Therapy (IV) Bottles Market report?

Ans: The main players in the Intravenous Therapy (IV) Bottles Market are Baxter Healthcare Limited, Vioser SA, B. Braun, Fresenius AG, JW Life Science, Polycine GmbH, Kraton Corporation, Metrix Company, Medicopack A/S, Sippex, ICU Medical, Technoflex S.A, Bausch Group, Euro Healthcare Pvt. Ltd., JOTOP Glass

What are the Application segmentation covered in the Intravenous Therapy (IV) Bottles Market report?

Ans: The Applications covered in the Intravenous Therapy (IV) Bottles Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Intravenous Therapy (IV) Bottles Market report?

Ans: The Types covered in the Intravenous Therapy (IV) Bottles Market report are Plastic IV Bottles, Glass IV Bottle

Recommended Reports

IV Therapy Supplies

Intravenous Drug Devices

Medical Glass & Packaging

1 Intravenous Therapy (IV) Bottles Market Overview
1.1 Product Definition
1.2 Intravenous Therapy (IV) Bottles by Type
1.2.1 Global Intravenous Therapy (IV) Bottles Market Value Comparison by Type (2024 VS 2031)
1.2.2 Plastic IV Bottles
1.2.3 Glass IV Bottle
1.3 Intravenous Therapy (IV) Bottles by Application
1.3.1 Global Intravenous Therapy (IV) Bottles Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Intravenous Therapy (IV) Bottles Market Size Estimates and Forecasts
1.4.1 Global Intravenous Therapy (IV) Bottles Revenue 2020-2031
1.4.2 Global Intravenous Therapy (IV) Bottles Sales 2020-2031
1.4.3 Global Intravenous Therapy (IV) Bottles Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Intravenous Therapy (IV) Bottles Market Competition by Manufacturers
2.1 Global Intravenous Therapy (IV) Bottles Sales Market Share by Manufacturers (2020-2025)
2.2 Global Intravenous Therapy (IV) Bottles Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Intravenous Therapy (IV) Bottles Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Intravenous Therapy (IV) Bottles, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intravenous Therapy (IV) Bottles, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravenous Therapy (IV) Bottles, Product Type & Application
2.7 Global Key Manufacturers of Intravenous Therapy (IV) Bottles, Date of Enter into This Industry
2.8 Global Intravenous Therapy (IV) Bottles Market Competitive Situation and Trends
2.8.1 Global Intravenous Therapy (IV) Bottles Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Intravenous Therapy (IV) Bottles Players Market Share by Revenue
2.8.3 Global Intravenous Therapy (IV) Bottles Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Intravenous Therapy (IV) Bottles Market Scenario by Region
3.1 Global Intravenous Therapy (IV) Bottles Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Intravenous Therapy (IV) Bottles Sales by Region: 2020-2031
3.2.1 Global Intravenous Therapy (IV) Bottles Sales by Region: 2020-2025
3.2.2 Global Intravenous Therapy (IV) Bottles Sales by Region: 2026-2031
3.3 Global Intravenous Therapy (IV) Bottles Revenue by Region: 2020-2031
3.3.1 Global Intravenous Therapy (IV) Bottles Revenue by Region: 2020-2025
3.3.2 Global Intravenous Therapy (IV) Bottles Revenue by Region: 2026-2031
3.4 North America Intravenous Therapy (IV) Bottles Market Facts & Figures by Country
3.4.1 North America Intravenous Therapy (IV) Bottles Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Intravenous Therapy (IV) Bottles Sales by Country (2020-2031)
3.4.3 North America Intravenous Therapy (IV) Bottles Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Intravenous Therapy (IV) Bottles Market Facts & Figures by Country
3.5.1 Europe Intravenous Therapy (IV) Bottles Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Intravenous Therapy (IV) Bottles Sales by Country (2020-2031)
3.5.3 Europe Intravenous Therapy (IV) Bottles Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravenous Therapy (IV) Bottles Market Facts & Figures by Region
3.6.1 Asia Pacific Intravenous Therapy (IV) Bottles Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Intravenous Therapy (IV) Bottles Sales by Region (2020-2031)
3.6.3 Asia Pacific Intravenous Therapy (IV) Bottles Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Intravenous Therapy (IV) Bottles Market Facts & Figures by Country
3.7.1 Latin America Intravenous Therapy (IV) Bottles Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Intravenous Therapy (IV) Bottles Sales by Country (2020-2031)
3.7.3 Latin America Intravenous Therapy (IV) Bottles Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravenous Therapy (IV) Bottles Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravenous Therapy (IV) Bottles Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Intravenous Therapy (IV) Bottles Sales by Country (2020-2031)
3.8.3 Middle East and Africa Intravenous Therapy (IV) Bottles Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Intravenous Therapy (IV) Bottles Sales by Type (2020-2031)
4.1.1 Global Intravenous Therapy (IV) Bottles Sales by Type (2020-2025)
4.1.2 Global Intravenous Therapy (IV) Bottles Sales by Type (2026-2031)
4.1.3 Global Intravenous Therapy (IV) Bottles Sales Market Share by Type (2020-2031)
4.2 Global Intravenous Therapy (IV) Bottles Revenue by Type (2020-2031)
4.2.1 Global Intravenous Therapy (IV) Bottles Revenue by Type (2020-2025)
4.2.2 Global Intravenous Therapy (IV) Bottles Revenue by Type (2026-2031)
4.2.3 Global Intravenous Therapy (IV) Bottles Revenue Market Share by Type (2020-2031)
4.3 Global Intravenous Therapy (IV) Bottles Price by Type (2020-2031)
5 Segment by Application
5.1 Global Intravenous Therapy (IV) Bottles Sales by Application (2020-2031)
5.1.1 Global Intravenous Therapy (IV) Bottles Sales by Application (2020-2025)
5.1.2 Global Intravenous Therapy (IV) Bottles Sales by Application (2026-2031)
5.1.3 Global Intravenous Therapy (IV) Bottles Sales Market Share by Application (2020-2031)
5.2 Global Intravenous Therapy (IV) Bottles Revenue by Application (2020-2031)
5.2.1 Global Intravenous Therapy (IV) Bottles Revenue by Application (2020-2025)
5.2.2 Global Intravenous Therapy (IV) Bottles Revenue by Application (2026-2031)
5.2.3 Global Intravenous Therapy (IV) Bottles Revenue Market Share by Application (2020-2031)
5.3 Global Intravenous Therapy (IV) Bottles Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Baxter Healthcare Limited
6.1.1 Baxter Healthcare Limited Company Information
6.1.2 Baxter Healthcare Limited Description and Business Overview
6.1.3 Baxter Healthcare Limited Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Baxter Healthcare Limited Intravenous Therapy (IV) Bottles Product Portfolio
6.1.5 Baxter Healthcare Limited Recent Developments/Updates
6.2 Vioser SA
6.2.1 Vioser SA Company Information
6.2.2 Vioser SA Description and Business Overview
6.2.3 Vioser SA Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Vioser SA Intravenous Therapy (IV) Bottles Product Portfolio
6.2.5 Vioser SA Recent Developments/Updates
6.3 B. Braun
6.3.1 B. Braun Company Information
6.3.2 B. Braun Description and Business Overview
6.3.3 B. Braun Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2020-2025)
6.3.4 B. Braun Intravenous Therapy (IV) Bottles Product Portfolio
6.3.5 B. Braun Recent Developments/Updates
6.4 Fresenius AG
6.4.1 Fresenius AG Company Information
6.4.2 Fresenius AG Description and Business Overview
6.4.3 Fresenius AG Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Fresenius AG Intravenous Therapy (IV) Bottles Product Portfolio
6.4.5 Fresenius AG Recent Developments/Updates
6.5 JW Life Science
6.5.1 JW Life Science Company Information
6.5.2 JW Life Science Description and Business Overview
6.5.3 JW Life Science Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2020-2025)
6.5.4 JW Life Science Intravenous Therapy (IV) Bottles Product Portfolio
6.5.5 JW Life Science Recent Developments/Updates
6.6 Polycine GmbH
6.6.1 Polycine GmbH Company Information
6.6.2 Polycine GmbH Description and Business Overview
6.6.3 Polycine GmbH Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Polycine GmbH Intravenous Therapy (IV) Bottles Product Portfolio
6.6.5 Polycine GmbH Recent Developments/Updates
6.7 Kraton Corporation
6.7.1 Kraton Corporation Company Information
6.7.2 Kraton Corporation Description and Business Overview
6.7.3 Kraton Corporation Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Kraton Corporation Intravenous Therapy (IV) Bottles Product Portfolio
6.7.5 Kraton Corporation Recent Developments/Updates
6.8 Metrix Company
6.8.1 Metrix Company Company Information
6.8.2 Metrix Company Description and Business Overview
6.8.3 Metrix Company Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Metrix Company Intravenous Therapy (IV) Bottles Product Portfolio
6.8.5 Metrix Company Recent Developments/Updates
6.9 Medicopack A/S
6.9.1 Medicopack A/S Company Information
6.9.2 Medicopack A/S Description and Business Overview
6.9.3 Medicopack A/S Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Medicopack A/S Intravenous Therapy (IV) Bottles Product Portfolio
6.9.5 Medicopack A/S Recent Developments/Updates
6.10 Sippex
6.10.1 Sippex Company Information
6.10.2 Sippex Description and Business Overview
6.10.3 Sippex Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sippex Intravenous Therapy (IV) Bottles Product Portfolio
6.10.5 Sippex Recent Developments/Updates
6.11 ICU Medical
6.11.1 ICU Medical Company Information
6.11.2 ICU Medical Description and Business Overview
6.11.3 ICU Medical Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2020-2025)
6.11.4 ICU Medical Intravenous Therapy (IV) Bottles Product Portfolio
6.11.5 ICU Medical Recent Developments/Updates
6.12 Technoflex S.A
6.12.1 Technoflex S.A Company Information
6.12.2 Technoflex S.A Description and Business Overview
6.12.3 Technoflex S.A Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Technoflex S.A Intravenous Therapy (IV) Bottles Product Portfolio
6.12.5 Technoflex S.A Recent Developments/Updates
6.13 Bausch Group
6.13.1 Bausch Group Company Information
6.13.2 Bausch Group Description and Business Overview
6.13.3 Bausch Group Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Bausch Group Intravenous Therapy (IV) Bottles Product Portfolio
6.13.5 Bausch Group Recent Developments/Updates
6.14 Euro Healthcare Pvt. Ltd.
6.14.1 Euro Healthcare Pvt. Ltd. Company Information
6.14.2 Euro Healthcare Pvt. Ltd. Description and Business Overview
6.14.3 Euro Healthcare Pvt. Ltd. Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Euro Healthcare Pvt. Ltd. Intravenous Therapy (IV) Bottles Product Portfolio
6.14.5 Euro Healthcare Pvt. Ltd. Recent Developments/Updates
6.15 JOTOP Glass
6.15.1 JOTOP Glass Company Information
6.15.2 JOTOP Glass Description and Business Overview
6.15.3 JOTOP Glass Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2020-2025)
6.15.4 JOTOP Glass Intravenous Therapy (IV) Bottles Product Portfolio
6.15.5 JOTOP Glass Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravenous Therapy (IV) Bottles Industry Chain Analysis
7.2 Intravenous Therapy (IV) Bottles Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravenous Therapy (IV) Bottles Production Mode & Process Analysis
7.4 Intravenous Therapy (IV) Bottles Sales and Marketing
7.4.1 Intravenous Therapy (IV) Bottles Sales Channels
7.4.2 Intravenous Therapy (IV) Bottles Distributors
7.5 Intravenous Therapy (IV) Bottles Customer Analysis
8 Intravenous Therapy (IV) Bottles Market Dynamics
8.1 Intravenous Therapy (IV) Bottles Industry Trends
8.2 Intravenous Therapy (IV) Bottles Market Drivers
8.3 Intravenous Therapy (IV) Bottles Market Challenges
8.4 Intravenous Therapy (IV) Bottles Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Intravenous Therapy (IV) Bottles Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Intravenous Therapy (IV) Bottles Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Intravenous Therapy (IV) Bottles Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Intravenous Therapy (IV) Bottles Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Intravenous Therapy (IV) Bottles Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Intravenous Therapy (IV) Bottles Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Intravenous Therapy (IV) Bottles Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Intravenous Therapy (IV) Bottles Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Intravenous Therapy (IV) Bottles, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Intravenous Therapy (IV) Bottles, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Intravenous Therapy (IV) Bottles, Product Type & Application
 Table 12. Global Key Manufacturers of Intravenous Therapy (IV) Bottles, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Intravenous Therapy (IV) Bottles by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Therapy (IV) Bottles as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Intravenous Therapy (IV) Bottles Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Intravenous Therapy (IV) Bottles Sales by Region (2020-2025) & (K Units)
 Table 18. Global Intravenous Therapy (IV) Bottles Sales Market Share by Region (2020-2025)
 Table 19. Global Intravenous Therapy (IV) Bottles Sales by Region (2026-2031) & (K Units)
 Table 20. Global Intravenous Therapy (IV) Bottles Sales Market Share by Region (2026-2031)
 Table 21. Global Intravenous Therapy (IV) Bottles Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Region (2020-2025)
 Table 23. Global Intravenous Therapy (IV) Bottles Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Region (2026-2031)
 Table 25. North America Intravenous Therapy (IV) Bottles Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Intravenous Therapy (IV) Bottles Sales by Country (2020-2025) & (K Units)
 Table 27. North America Intravenous Therapy (IV) Bottles Sales by Country (2026-2031) & (K Units)
 Table 28. North America Intravenous Therapy (IV) Bottles Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Intravenous Therapy (IV) Bottles Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Intravenous Therapy (IV) Bottles Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Intravenous Therapy (IV) Bottles Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Intravenous Therapy (IV) Bottles Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Intravenous Therapy (IV) Bottles Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Intravenous Therapy (IV) Bottles Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Intravenous Therapy (IV) Bottles Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Intravenous Therapy (IV) Bottles Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Intravenous Therapy (IV) Bottles Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Intravenous Therapy (IV) Bottles Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Intravenous Therapy (IV) Bottles Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Intravenous Therapy (IV) Bottles Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Intravenous Therapy (IV) Bottles Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Intravenous Therapy (IV) Bottles Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Intravenous Therapy (IV) Bottles Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Intravenous Therapy (IV) Bottles Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Intravenous Therapy (IV) Bottles Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Intravenous Therapy (IV) Bottles Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Intravenous Therapy (IV) Bottles Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Intravenous Therapy (IV) Bottles Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Intravenous Therapy (IV) Bottles Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Intravenous Therapy (IV) Bottles Sales (K Units) by Type (2020-2025)
 Table 51. Global Intravenous Therapy (IV) Bottles Sales (K Units) by Type (2026-2031)
 Table 52. Global Intravenous Therapy (IV) Bottles Sales Market Share by Type (2020-2025)
 Table 53. Global Intravenous Therapy (IV) Bottles Sales Market Share by Type (2026-2031)
 Table 54. Global Intravenous Therapy (IV) Bottles Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Intravenous Therapy (IV) Bottles Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Type (2020-2025)
 Table 57. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Type (2026-2031)
 Table 58. Global Intravenous Therapy (IV) Bottles Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Intravenous Therapy (IV) Bottles Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Intravenous Therapy (IV) Bottles Sales (K Units) by Application (2020-2025)
 Table 61. Global Intravenous Therapy (IV) Bottles Sales (K Units) by Application (2026-2031)
 Table 62. Global Intravenous Therapy (IV) Bottles Sales Market Share by Application (2020-2025)
 Table 63. Global Intravenous Therapy (IV) Bottles Sales Market Share by Application (2026-2031)
 Table 64. Global Intravenous Therapy (IV) Bottles Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Intravenous Therapy (IV) Bottles Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Application (2020-2025)
 Table 67. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Application (2026-2031)
 Table 68. Global Intravenous Therapy (IV) Bottles Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Intravenous Therapy (IV) Bottles Price (US$/Unit) by Application (2026-2031)
 Table 70. Baxter Healthcare Limited Company Information
 Table 71. Baxter Healthcare Limited Description and Business Overview
 Table 72. Baxter Healthcare Limited Intravenous Therapy (IV) Bottles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Baxter Healthcare Limited Intravenous Therapy (IV) Bottles Product
 Table 74. Baxter Healthcare Limited Recent Developments/Updates
 Table 75. Vioser SA Company Information
 Table 76. Vioser SA Description and Business Overview
 Table 77. Vioser SA Intravenous Therapy (IV) Bottles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Vioser SA Intravenous Therapy (IV) Bottles Product
 Table 79. Vioser SA Recent Developments/Updates
 Table 80. B. Braun Company Information
 Table 81. B. Braun Description and Business Overview
 Table 82. B. Braun Intravenous Therapy (IV) Bottles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. B. Braun Intravenous Therapy (IV) Bottles Product
 Table 84. B. Braun Recent Developments/Updates
 Table 85. Fresenius AG Company Information
 Table 86. Fresenius AG Description and Business Overview
 Table 87. Fresenius AG Intravenous Therapy (IV) Bottles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Fresenius AG Intravenous Therapy (IV) Bottles Product
 Table 89. Fresenius AG Recent Developments/Updates
 Table 90. JW Life Science Company Information
 Table 91. JW Life Science Description and Business Overview
 Table 92. JW Life Science Intravenous Therapy (IV) Bottles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. JW Life Science Intravenous Therapy (IV) Bottles Product
 Table 94. JW Life Science Recent Developments/Updates
 Table 95. Polycine GmbH Company Information
 Table 96. Polycine GmbH Description and Business Overview
 Table 97. Polycine GmbH Intravenous Therapy (IV) Bottles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Polycine GmbH Intravenous Therapy (IV) Bottles Product
 Table 99. Polycine GmbH Recent Developments/Updates
 Table 100. Kraton Corporation Company Information
 Table 101. Kraton Corporation Description and Business Overview
 Table 102. Kraton Corporation Intravenous Therapy (IV) Bottles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Kraton Corporation Intravenous Therapy (IV) Bottles Product
 Table 104. Kraton Corporation Recent Developments/Updates
 Table 105. Metrix Company Company Information
 Table 106. Metrix Company Description and Business Overview
 Table 107. Metrix Company Intravenous Therapy (IV) Bottles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Metrix Company Intravenous Therapy (IV) Bottles Product
 Table 109. Metrix Company Recent Developments/Updates
 Table 110. Medicopack A/S Company Information
 Table 111. Medicopack A/S Description and Business Overview
 Table 112. Medicopack A/S Intravenous Therapy (IV) Bottles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Medicopack A/S Intravenous Therapy (IV) Bottles Product
 Table 114. Medicopack A/S Recent Developments/Updates
 Table 115. Sippex Company Information
 Table 116. Sippex Description and Business Overview
 Table 117. Sippex Intravenous Therapy (IV) Bottles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Sippex Intravenous Therapy (IV) Bottles Product
 Table 119. Sippex Recent Developments/Updates
 Table 120. ICU Medical Company Information
 Table 121. ICU Medical Description and Business Overview
 Table 122. ICU Medical Intravenous Therapy (IV) Bottles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. ICU Medical Intravenous Therapy (IV) Bottles Product
 Table 124. ICU Medical Recent Developments/Updates
 Table 125. Technoflex S.A Company Information
 Table 126. Technoflex S.A Description and Business Overview
 Table 127. Technoflex S.A Intravenous Therapy (IV) Bottles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Technoflex S.A Intravenous Therapy (IV) Bottles Product
 Table 129. Technoflex S.A Recent Developments/Updates
 Table 130. Bausch Group Company Information
 Table 131. Bausch Group Description and Business Overview
 Table 132. Bausch Group Intravenous Therapy (IV) Bottles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Bausch Group Intravenous Therapy (IV) Bottles Product
 Table 134. Bausch Group Recent Developments/Updates
 Table 135. Euro Healthcare Pvt. Ltd. Company Information
 Table 136. Euro Healthcare Pvt. Ltd. Description and Business Overview
 Table 137. Euro Healthcare Pvt. Ltd. Intravenous Therapy (IV) Bottles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Euro Healthcare Pvt. Ltd. Intravenous Therapy (IV) Bottles Product
 Table 139. Euro Healthcare Pvt. Ltd. Recent Developments/Updates
 Table 140. JOTOP Glass Company Information
 Table 141. JOTOP Glass Description and Business Overview
 Table 142. JOTOP Glass Intravenous Therapy (IV) Bottles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. JOTOP Glass Intravenous Therapy (IV) Bottles Product
 Table 144. JOTOP Glass Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Intravenous Therapy (IV) Bottles Distributors List
 Table 148. Intravenous Therapy (IV) Bottles Customers List
 Table 149. Intravenous Therapy (IV) Bottles Market Trends
 Table 150. Intravenous Therapy (IV) Bottles Market Drivers
 Table 151. Intravenous Therapy (IV) Bottles Market Challenges
 Table 152. Intravenous Therapy (IV) Bottles Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Intravenous Therapy (IV) Bottles
 Figure 2. Global Intravenous Therapy (IV) Bottles Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Intravenous Therapy (IV) Bottles Market Share by Type: 2024 & 2031
 Figure 4. Plastic IV Bottles Product Picture
 Figure 5. Glass IV Bottle Product Picture
 Figure 6. Global Intravenous Therapy (IV) Bottles Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Intravenous Therapy (IV) Bottles Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Others
 Figure 11. Global Intravenous Therapy (IV) Bottles Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Intravenous Therapy (IV) Bottles Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Intravenous Therapy (IV) Bottles Sales (2020-2031) & (K Units)
 Figure 14. Global Intravenous Therapy (IV) Bottles Average Price (US$/Unit) & (2020-2031)
 Figure 15. Intravenous Therapy (IV) Bottles Report Years Considered
 Figure 16. Intravenous Therapy (IV) Bottles Sales Share by Manufacturers in 2024
 Figure 17. Global Intravenous Therapy (IV) Bottles Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Intravenous Therapy (IV) Bottles Players: Market Share by Revenue in Intravenous Therapy (IV) Bottles in 2024
 Figure 19. Intravenous Therapy (IV) Bottles Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Intravenous Therapy (IV) Bottles Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Intravenous Therapy (IV) Bottles Sales Market Share by Country (2020-2031)
 Figure 22. North America Intravenous Therapy (IV) Bottles Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Intravenous Therapy (IV) Bottles Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Intravenous Therapy (IV) Bottles Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Intravenous Therapy (IV) Bottles Sales Market Share by Country (2020-2031)
 Figure 26. Europe Intravenous Therapy (IV) Bottles Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Intravenous Therapy (IV) Bottles Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Intravenous Therapy (IV) Bottles Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Intravenous Therapy (IV) Bottles Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Intravenous Therapy (IV) Bottles Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Intravenous Therapy (IV) Bottles Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Intravenous Therapy (IV) Bottles Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Intravenous Therapy (IV) Bottles Revenue Market Share by Region (2020-2031)
 Figure 34. China Intravenous Therapy (IV) Bottles Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Intravenous Therapy (IV) Bottles Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Intravenous Therapy (IV) Bottles Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Intravenous Therapy (IV) Bottles Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Intravenous Therapy (IV) Bottles Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Intravenous Therapy (IV) Bottles Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Intravenous Therapy (IV) Bottles Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Intravenous Therapy (IV) Bottles Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Intravenous Therapy (IV) Bottles Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Intravenous Therapy (IV) Bottles Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Intravenous Therapy (IV) Bottles Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Intravenous Therapy (IV) Bottles Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Intravenous Therapy (IV) Bottles Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Intravenous Therapy (IV) Bottles Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Intravenous Therapy (IV) Bottles Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Intravenous Therapy (IV) Bottles Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Intravenous Therapy (IV) Bottles Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Intravenous Therapy (IV) Bottles Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Intravenous Therapy (IV) Bottles Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Intravenous Therapy (IV) Bottles Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Intravenous Therapy (IV) Bottles by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Intravenous Therapy (IV) Bottles by Type (2020-2031)
 Figure 56. Global Intravenous Therapy (IV) Bottles Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Intravenous Therapy (IV) Bottles by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Intravenous Therapy (IV) Bottles by Application (2020-2031)
 Figure 59. Global Intravenous Therapy (IV) Bottles Price (US$/Unit) by Application (2020-2031)
 Figure 60. Intravenous Therapy (IV) Bottles Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart